Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
35.98
-0.30 (-0.83%)
At close: Jun 3, 2026, 4:00 PM EDT
35.40
-0.58 (-1.61%)
After-hours: Jun 3, 2026, 7:22 PM EDT
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of $6.68 billion as of June 3, 2026. Its market cap has increased by 24.57% in one year.
Market Cap
6.68B
Enterprise Value
6.24B
1-Year Change
24.57%
Ranking
Category
Stock Price
$35.98
Market Cap Chart
Since June 5, 2020, Legend Biotech's market cap has increased from $4.79B to $6.68B, an increase of 39.63%. That is a compound annual growth rate of 5.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 6.68B | 66.44% |
| Dec 31, 2025 | 4.02B | -32.74% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmunityBio | 7.52B |
| Nuvalent | 7.12B |
| Vaxcyte | 6.78B |
| ABIVAX Société Anonyme | 6.59B |
| Immunovant | 6.40B |
| Spyre Therapeutics | 6.38B |
| Apogee Therapeutics | 6.31B |
| Centessa Pharmaceuticals | 6.17B |